MARKET

CRBP

CRBP

Corbus Pharmaceu
NASDAQ
0.1233
-0.0057
-4.42%
Pre Market: 0.1215 -0.0018 -1.46% 09:06 12/07 EST
OPEN
0.1251
PREV CLOSE
0.1290
HIGH
0.1300
LOW
0.1206
VOLUME
94.66K
TURNOVER
--
52 WEEK HIGH
0.8651
52 WEEK LOW
0.1000
MARKET CAP
15.45M
P/E (TTM)
-0.3702
1D
5D
1M
3M
1Y
5Y
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Benzinga · 5d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 5d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 6d ago
Why Okta Shares Are Trading Higher By Around 14%; Here Are 27 Stocks Moving Premarket
Benzinga · 6d ago
Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session
Benzinga · 6d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 6d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 11/30 13:09
Why Horizon Therapeutics Shares Are Trading Higher By Over 30%; Here Are 32 Stocks Moving Premarket
Benzinga · 11/30 12:42
More
About CRBP
Corbus Pharmaceuticals Holdings, Inc. is focused on the development of immune modulators that have application in disease states spanning from immuno-oncology to fibrosis. The Company’s pipeline includes anti-integrin monoclonal antibodies that block activation of TGFβ and small molecules that activate or inhibit the endocannabinoid system. The Company pipeline includes Anti-integrin monoclonal antibodies (mAbs), Cannabinoid receptor type 1 (CB1) and Lenabasum. The mAbs is for the treatment of cancer and fibrosis that inhibit the activation of Transforming growth factor β (TGFβ). Its CRB-601 is an anti-αvβ8 mAb being developed as a potential treatment for solid tumors in combination with existing therapies, including checkpoint inhibitors. Cannabinoid receptor type 1 (CB1) is an inverse agonist designed to treat obesity and related metabolic diseases. Lenabasum is a novel, synthetic, oral molecule that selectively activates cannabinoid receptor type 2 (CB2).

Webull offers kinds of Corbus Pharmaceuticals Holdings Inc stock information, including NASDAQ:CRBP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRBP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CRBP stock methods without spending real money on the virtual paper trading platform.